Medical devices refer to instruments, machines or appliances essential to the delivery of healthcare and designed for diagnosis, monitoring, cure or prevention of any disease or for some other specific medical purposes. The medical devices market can be classified into the following segments: general medical, orthopedic, cardiovascular, respiratory, home healthcare, surgical devices, etc.
North America has the competitive advantage on the market, accounting for the market share of above 45%. Technological advancements in medicine, introduction of new treatment modes, product innovations, expansion of the medical facilities infrastructure, rising health awareness, growing population and the increasing number of elderly people are the key drivers of the global medical devices market. Abbott Labs, Johnson & Johnson, Baxter, Medtronic, Becton Dickinson, Boston Scientific, Stryker Corporation, GE Healthcare Technologies and Beckman Coulter are amid the most recognized participants of the industry.
The catalogue encompasses a wealthy collection of research reports providing extensive analyses of the medical devices market at all geographical levels possible. The researches present the essential findings on the market dynamics, identify the main market barriers and opportunities. The reports also evaluate the market competition and point out top market players. Besides, the future forecasts for the market are revealed in the research reports.
Publications found:
58,440
Sort by:
Asia Pacific Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
US$ 2,100.00
The Asia Pacific deep brain simulation market is expected to grow from US$ 98.35 million in 2022 to US$ 188.04 million by 2030. It is estimated to grow at a CAGR of 8.4% from 2022 to 2030. Technologi...
October 2023
91 pages
Europe Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
US$ 2,100.00
The Europe deep brain simulation market is expected to grow from US$ 169.14 million in 2022 to US$ 319.88 million by 2030. It is estimated to grow at a CAGR of 8.3% from 2022 to 2030. Increasing Dema...
October 2023
95 pages
Middle East & Africa Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
US$ 2,100.00
The Middle East & Africa radiopharmaceutical theranostics market was valued at US$ 89.44 million in 2022 and is expected to reach US$ 157.30 million by 2028; it is estimated to register a CAGR of 9.9%...
October 2023
146 pages
South & Central America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
US$ 2,100.00
The South & Central America radiopharmaceutical theranostics market was valued at US$ 129.48 million in 2022 and is expected to reach US$ 233.71 million by 2028; it is estimated to register a CAGR of...
October 2023
145 pages
